Atlas Antibodies: Selected partner

Atlas Antibodies, founded by researchers involved in the Human Protein Atlas project, is renowned for producing highly validated research antibodies and advanced reagents for biomedical research.

As part of Atlas Antibodies, evitria now enjoys substantial enhancements in capabilities and resources, enabling it to offer even greater value to its recombinant antibody expression services.

Key facts

• Specialization: Production of highly validated polyclonal and monoclonal antibodies
• Technology: Advanced platforms and antibody validation techniques
• Services: Antibody production services, including recombinant and afucosylated antibodies, as well as a wide range of other research reagents
• Website: atlasantibodies.com

About Atlas Antibodies

Atlas Antibodies was founded in 2006 by researchers from the Royal Institute of Technology and Uppsala University, stemming from the Human Protein Atlas project. The company is dedicated to providing high-quality antibodies and advanced reagents for biomedical research.

Their extensive portfolio includes Triple A Polyclonals, PrecisA Monoclonals, and various other antibody types, which are widely used in cancer, neuroscience, and cell biology research.

Unlock the full potential of your research with Atlas Antibodies and evitria

As part of Atlas Antibodies, evitria benefits from enhanced capabilities and resources, enabling it to offer even greater value to its customers. This strategic acquisition combines Atlas Antibodies’ extensive experience in producing highly validated research antibodies with evitria’s expertise in custom recombinant antibody expression.

By integrating evitria’s specialized CHO cell-based transient expression systems with Atlas Antibodies’ validated reagent production, the partnership ensures that researchers receive consistent, high-quality results tailored to their specific needs.